Author Correction: Neutrophils support lung colonization of metastasis-initiating breast cancer cells (Nature, (2015), 528, 7582, (413-417), 10.1038/nature16140);Neutrophils support lung colonization of metastasis-initiating breast cancer cells

Nature

Volumn 528, Issue 7582, 2015, Pages 413-417

  Wculek, Stefanie K ^a   Malanchi, Ilaria ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE; RAG1 PROTEIN; LIPOXYGENASE INHIBITOR;

CANCER; DRUG; INHIBITION; RODENT; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EOSINOPHIL; HISTOLOGY; IN VITRO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MACROPHAGE; METASTASIS INHIBITION; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ANIMAL; BREAST NEOPLASMS; CANCER TRANSPLANTATION; DISEASE COURSE; DISEASE MODEL; DRUG EFFECTS; FEMALE; LUNG NEOPLASMS; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NEOPLASM METASTASIS; PATHOLOGY; PROCEDURES; SECONDARY;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; LUNG NEOPLASMS; MICE; MOLECULAR TARGETED THERAPY; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEUTROPHILS; TUMOR MICROENVIRONMENT;

EID: 84950299450     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-019-1328-7     Document Type: Erratum

References (39)

1. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nature Med. 19, 1423-1437 (2013).
2. Bald, T. et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507, 109-113 (2014).
3. Galdiero, M. R. et al. Tumor associated macrophages and neutrophils in cancer. Immunobiology 218, 1402-1410 (2013).
4. Finisguerra, V. et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 522, 349-353 (2015).
5. Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nature Cell Biol. 8, 1369-1375 (2006).
6. Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44 (2009).
7. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
8. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2012).
9. Calon, A. et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571-584 (2012).
10. Oskarsson, T., Batlle, E. & Massagué, J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 14, 306-321 (2014).
11. Coffelt, S. B. et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345-348 (2015).
12. Luu, N. T., Rainger, G. E., Buckley, C. D. & Nash, G. B. CD31 regulates direction and rate of neutrophil migration over and under endothelial cells. J. Vasc. Res. 40, 467-479 (2003).
13. Condamine, T., Ramachandran, I., Youn, J. I. & Gabrilovich, D. I. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu. Rev. Med. 66, 97-110 (2015).
14. Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breasttumour metastasis. Nature 475, 222-225 (2011).
15. Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584 (2013).
16. Korkaya, H., Liu, S. & Wicha, M. S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 121, 3804-3809 (2011).
17. Tsuyada, A. et al. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res. 72, 2768-2779 (2012).
18. + myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Res. 70, 6139-6149 (2010).
19. Snoussi, K., Strosberg, A. D., Bouaouina, N., Ben Ahmed, S. & Chouchane, L. Genetic variation in pro-inflammatory cytokines (interleukin-1β, interleukin-1α and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur. Cytokine Netw. 16, 253-260 (2005).
20. Wang, D. & Dubois, R. N. Eicosanoids and cancer. Nature Rev. Cancer 10, 181-193 (2010).
21. Cho, N. K., Joo, Y. C., Wei, J. D., Park, J. I. & Kim, J. H. BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development. Am. J. Cancer Res. 3, 347-355 (2013).
22. Kanaoka, Y. & Boyce, J. A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173, 1503-1510 (2004).
23. Hiraga, T., Ito, S. & Nakamura, H. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential. Oncol. Rep. 25, 289-296 (2011).
24. - breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 8, R59 (2006).
25. Lo, P. K. et al. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Oncogene 31, 2614-2626 (2012).
26. 4-induced keratin phosphorylation and reorganization of pancreatic cancer cells. Biochim. Biophys. Acta 1823, 2120-2129 (2012).
27. Wenzel, S. E. & Kamada, A. K. Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma. Ann. Pharmacother. 30, 858-864 (1996).
28. Donskov, F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol. 23, 200-207 (2013).
29. Han, Y. et al. Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer. Breast Cancer Res. Treat. 131, 483-490 (2012).
30. Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961 (1992).
31. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. & Nishimune, Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313-319 (1997).
32. Lieschke, G. J. et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746 (1994).
33. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
34. Cao, Y. A. et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl Acad. Sci. USA 101, 221-226 (2004).
35. Ivanova, A. et al. In vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment A. Genesis 43, 129-135 (2005).
36. Tkalcevic, J. et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12, 201-210 (2000).
37. Chen, X. S., Sheller, J. R., Johnson, E. N. & Funk, C. D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372, 179-182 (1994).
38. Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S. & Albina, J. E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64-70 (2008).
39. Bao, Y. & Cao, X. Revisiting the protective and pathogenic roles of neutrophils: Ly-6G is key! Eur. J. Immunol. 41, 2535-2538 (2011).